ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2021.0.152 2021.0.152 2022-03-312022-03-311No description of principal activity2021-04-011truetrue 09733434 2021-04-01 2022-03-31 09733434 2020-04-01 2021-03-31 09733434 2022-03-31 09733434 2021-03-31 09733434 c:Director1 2021-04-01 2022-03-31 09733434 c:EntityHasNeverTraded 2021-04-01 2022-03-31 09733434 c:Micro-entities 2021-04-01 2022-03-31 09733434 c:AuditExempt-NoAccountantsReport 2021-04-01 2022-03-31 09733434 c:FullAccounts 2021-04-01 2022-03-31 09733434 c:PrivateLimitedCompanyLtd 2021-04-01 2022-03-31 iso4217:GBP xbrli:pure
Registered number: 09733434












HAWKMOOR MEDICAL LIMITED
UNAUDITED
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED
 31 MARCH 2022




























 



img32d1.png
01483 755 399
hamlyns.com

 
HAWKMOOR MEDICAL LIMITED
REGISTERED NUMBER: 09733434

BALANCE SHEET
AS AT 31 MARCH 2022

2022
2021
£
£


Current assets
100
100

Net current assets
 
 
100
 
 
100

Total assets less current liabilities
100
100


Net assets
100
100



Capital and reserves
100
100


Notes


General information

Hawkmoor Medical Limited is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address are as below:
Registered number: 09733434
Registered office: Sundial House, 98 High Street, Horsell, Woking, Surrey, GU21 4SU.


Average number of employees

The average monthly number of employees, including directors, during the year was 1 (2021 - 1).

The Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

The members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 14 November 2022.




M Higgins
Director

Page 1